The pharmaceutical industry is currently experiencing a transformative period marked by evolving clinical trial dynamics, increased R&D investment, and significant post-pandemic adjustments. This transformation is primarily driven by the complexities of modern trials, the demands for personalized
Respiratory Syncytial Virus (RSV) is a common virus that infects nearly all children by the age of two, but while most cases are mild, some children experience severe respiratory illness that requires hospitalization. The mechanisms behind this severity, especially the role and dysfunction of
In a groundbreaking study conducted by researchers at UF Health Cancer Center and their international partners, scientists have found compelling evidence that a toxin produced by a common foodborne bacterium, Campylobacter jejuni (C. jejuni), significantly accelerates the spread of colorectal
Recent research from the University of Alabama at Birmingham (UAB) has unveiled groundbreaking insights into the replication mechanism of the BK polyomavirus (BKPyV), a major cause of kidney transplant failure. This discovery could pave the way for new treatments to protect transplanted kidneys
Prostate cancer has become an alarming health issue, particularly among African men, who are increasingly found to be at higher risk compared to men of other ethnicities. Various studies point towards genetic factors playing a significant role in this elevated risk, coupled with inadequate
Newcells Biotech, a leading partner in drug discovery recognized for its development of in vitro models and custom assay services, has recently announced a significant milestone by securing an additional £1.2 million in funding from its current investors, including Mercia Ventures, Northstar
